PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.
PharmNovo has raised $16.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
PharmNovo's investors include Almi Invest, Sciety, EIC Accelerator, Karolinska, Polynom Investment.
PharmNovo is headquartered in Lund, Sweden.
PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.
PharmNovo is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PharmNovo — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/pharmnovo. Accessed September 4, 2026.
VCBacked. (2024). PharmNovo — Funding & Investors. Retrieved September 4, 2026, from https://www.vcbacked.co/company/pharmnovo
{{cite web |title=PharmNovo — Funding & Investors |url=https://www.vcbacked.co/company/pharmnovo |website=VCBacked |access-date=September 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated